KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Short-Term Debt issuances (2017 - 2025)

Historic Short-Term Debt issuances for Boston Scientific (BSX) over the last 8 years, with Q1 2025 value amounting to -$192.0 million.

  • Boston Scientific's Short-Term Debt issuances changed N/A to -$192.0 million in Q1 2025 from the same period last year, while for Dec 2025 it was -$5.0 million, marking a year-over-year decrease of 10267.38%. This contributed to the annual value of -$196.0 million for FY2025, which is 20481.28% down from last year.
  • As of Q1 2025, Boston Scientific's Short-Term Debt issuances stood at -$192.0 million.
  • Boston Scientific's Short-Term Debt issuances' 5-year high stood at $223.0 million during Q1 2022, with a 5-year trough of -$192.0 million in Q1 2025.
  • Moreover, its 4-year median value for Short-Term Debt issuances was -$41.0 million (2023), whereas its average is -$1.4 million.
  • The largest annual percentage gain for Boston Scientific's Short-Term Debt issuances in the last 5 years was 15362.32% (2023), contrasted with its biggest fall of 7354.84% (2023).
  • Over the past 4 years, Boston Scientific's Short-Term Debt issuances (Quarter) stood at -$155.0 million in 2022, then soared by 73.55% to -$41.0 million in 2023, then surged by 556.1% to $187.0 million in 2024, then tumbled by 202.67% to -$192.0 million in 2025.
  • Its last three reported values are -$192.0 million in Q1 2025, $187.0 million for Q4 2024, and -$41.0 million during Q3 2023.